Integrated gut virome and bacteriome dynamics in COVID-19 patients/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Atrayees on 2023-7-10

Curated date: 2021/07/02

Curator: Claregrieve1

Revision editor(s): Claregrieve1, WikiWorks, Peace Sandy

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
COVID-19 2019 novel coronavirus,2019 novel coronavirus infection,2019-nCoV,2019-nCoV infection,beta-CoV,beta-CoVs,betacoronavirus,coronavirus disease 2019,SARS-coronavirus 2,SARS-CoV-2,severe acute respiratory syndrome coronavirus 2,severe acute respiratory syndrome coronavirus 2 infectious disease,β-coronavirus,β-CoV,β-CoVs,COVID-19,cOVID-19
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
COVID-19 patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with COVID-19
Group 0 sample size Number of subjects in the control (unexposed) group
5
Group 1 sample size Number of subjects in the case (exposed) group
13

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Mann-Whitney (Wilcoxon)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased

Signature 1

Reviewed Marked as Reviewed by Atrayees on 2023-7-10

Curated date: 2021/07/02

Curator: Claregrieve1

Revision editor(s): Claregrieve1

Source: Figure 3d

Description: Differential abundance in microbial taxa between healthy controls and COVID-19 patients

Abundance in Group 1: increased abundance in COVID-19 patients

NCBI Quality ControlLinks
Mediterraneibacter gnavus
unclassified Eggerthella
unclassified Coprobacillus
Thomasclavelia ramosa
Eggerthella lenta
Lachnospiraceae bacterium 2_1_58FAA
Lachnospiraceae bacterium 1_4_56FAA

Revision editor(s): Claregrieve1

Signature 2

Reviewed Marked as Reviewed by Atrayees on 2023-7-10

Curated date: 2021/07/02

Curator: Claregrieve1

Revision editor(s): Claregrieve1

Source: Figure 3d

Description: Differential abundance in microbial taxa between healthy controls and COVID-19 patients

Abundance in Group 1: decreased abundance in COVID-19 patients

NCBI Quality ControlLinks
Alistipes ihumii AP11
Roseburia intestinalis
Burkholderiales bacterium 1_1_47
Anaerobutyricum hallii
Parasutterella excrementihominis
Alistipes indistinctus
Coprobacter fastidiosus
Lachnospira eligens
Bacteroidales bacterium
Bacteroides salyersiae
Odoribacter splanchnicus
Alistipes shahii
Ruminococcus bromii
Phocaeicola massiliensis

Revision editor(s): Claregrieve1